Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A "Window Trial" on Curcumin, the Active Compound in Turmeric, for Invasive Breast Cancer Primary Tumors

NCT03980509 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT03980509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03980509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A "Window Trial" on Curcumin, the Active Compound in Turmeric, for Invasive Breast Cancer Primary Tumors
Lead sponsor
Medical University of South Carolina
Phase
Phase 1
Overall status
Completed
Start date
January 29, 2020
Completion date
March 24, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer